Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing
Concerns that well-funded Chinese companies will swoop in to grab new ideas for their own drug development are shaping an industry unaccustomed to such secrecy.
閱讀原始報道 ↗最新財經標題及出版者提供的簡短摘要。點擊來源連結可到原網站閱讀全文。
顯示第 1–2 則,共 2 則報道
Concerns that well-funded Chinese companies will swoop in to grab new ideas for their own drug development are shaping an industry unaccustomed to such secrecy.
閱讀原始報道 ↗The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
閱讀原始報道 ↗標題及簡短摘要屬於所列出版者。全文在原網站開啟,部分文章可能需要訂閱。僅供資訊參考及教育用途。